Metallothionein Content Correlates with the Sensitivity of Human Small Cell Lung Cancer Cell Lines to Cisplatin

Cancer Research

Volumn 51, Issue 12, 1991, Pages 3237-3242

  Komiya, Kazuhide ^c   Matsuda, Tamotsu ^c   Nishio, Kazuto ^a   Ohmori, Tohru ^a   Sugimoto, Yoshikazu ^a   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; METALLOTHIONEIN; VINCRISTINE;

ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; TISSUE LEVEL;

ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; CELL LINE; CELL SURVIVAL; CISPLATIN; DRUG RESISTANCE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMAN; KINETICS; LUNG NEOPLASMS; METALLOTHIONEIN; SUPPORT, NON-U.S. GOV'T;

EID: 0025781307     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Tamura, T., Fukuoka, M., Furuse, K., Ikegami. H., Saijo, N., and Suemasu, K. Japanese multicenter randomized trial: Cyclophosphamide/Adriamycin/ vincristine (CAV) versus cisplatin/etoposide (PVP) versus CAV alternating with PVP (CAV-PVP) in patients with small cell lung cancer. Proc. Am. Soc. Clin. Oncol., 8: 220, 1989.
2. Fujiwara, Y., Sugimoto, Y., Kasahara, K., Bungo. M., Yamakido, M., Tew, K. I., and Saijo, N. Determinant of drug response in a cisplatin-resistant human lung cancer cell line. Jpn. J. Cancer Res., 81: 527-535, 1990.
3. Andrews, P. A., and Howell, S. B. Cellular pharmacology of cisplatin: Perspectives on mechanisms of acquired resistance. Cancer Cells, 2:. 15-43. 1990.
4. Andrews. P. A., Sriharasha. V., Mann. S. C., and Howcll. S. B. cis-diamminedichloro-platinum(ll) accumulation in sensitive and resistant human ovarian carcinoma cells. Cancer Res., 48:68-73. 1988.
5. Krakker. A. J., and Moore. C. W. Accumulation of a'.v-diamminedichloroi'l. minimi Mand platinum analogues by plutinum-resistant murine leukemia cells in vitro. Cancer Res., 4S: 9-13. 1988.
6. Richon. V. M., Schulte. N., and Eastman. A. Multiple mechanisms of resistance to a'.v-diamminedichloroplalinum(ll) in murine leukemia LI210 cells. Cancer Res., 47: 2056-2061, 1987.
7. Masuda. H., Ozols. R. F., Lai, G. M., Fojo. A., Rothenberg. M., and Hamilton. T. C. Increased DNA repair as a mechanism of acquired resistance to m-diamminedichloroplatinum in human ovarian cancer cell lines. Cancer Res., 8.-5713-5716. 1988.
8. Eastman. A., and Schulte. N. Enhanced DNA repair as a mechanism of resistance to a.v-diamminedichloroplatinuni(ll). Biochemistry, 27: 4730-4734. 1988.
9. Shebani. N., Jennerwein. M. M., and Eastman. A. DNA repair in cells sensitive and resistant to d.v-diamminedichloroplatinum(II) host cell reacti vation of damaged plasmid DNA. Biochemistry, 28: 3120-3124. 1989.
10. Dulik. D. M., and Fenselau. C. Conversion of mclphalan to 4-(glutathinyl) phenyalanine. A novel mechanism for conjugation by glutathione. S'-transferases/ Drug Melab. Dispos., IS: 195-199, 1987.
11. Wang, Y., Teicher. B. A., Shea. T. C., Holden. S. A., Rosbe, K. W., AI-Achi. A., and Hcnner. W. D. Cross-resistance and glutathione-S-transferase-ir levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res., 4V: 6185-6192. 1989.
12. Nakagawa, K., Vokota. J., Wada. Y., Sasaki, Y., Fujiwara. Y., Sakai. M., Muramatsu. M., Terasaki. T., Tsunokawa. Y., Terada. M., and Saijo. N. Levels of glutalhione S-transferase amRN'A in human lung cancer cell lines correlate with the resistance to cisplatin and carboplatin. Jpn. J. Cancer Res., Ti: 301-304, 1988.
13. Nakagawa. K., Saijo. N., Tsuchida. S., Sakai. M., Tsunokawa. Y., Yokota. J., Muramatsu. M., Sato. K., Terada. M., and Tew. K. D. Glutathionc-.Stransferase T as a determinant of drug resistance in transfectant cell lines. J. Biol. Chem., 268: 4296-4301. 1990.
14. Andrews, P. A., Murphy. M. P., and Howcll. S. B. Melallothionein-mediated cisplatin resistance in human ovarian carcinoma cells. Cancer Chcniother. Pharmacol., 19: 149-154. 1987.
15. Kelley. S. L., Basu, A., Teicher. B. A., Hacker. M. P., Hamer. D. H., and Lazo. J. S. Overexpression of mctallothionein confers resistance to anticancer drugs. Science (Washington DC). 241: 1813-1815. 1988.
16. Hong. W. S., Saijo. N., Sasaki. Y., Minato, K., Nakano, H., Nakagawa. K., Fujiwara. Y., Nomura. M., and Twentyman. P. R. Establishment and char acterization of cisplatin-resistant sublines of human lung cancer cell lines. Int. J. Cancer. 41: 462-467. 1988.
17. Twentyman. P. R., Fox. N. E., Wright. K. A., and Blechen. N. M. Derivation and preliminary characterisation of Adriamycin resistant lines of human lung cancer cells. Br. J. Cancer. 53: 529-537. 1986.
18. Kohn. K. W., Fwing. R. A. G., Erickson. L. C. and Zwelling. L. A. Measurement of strand breaks and cross-links by alkaline elution. in: E. C. Friedberg and P. C. Hanawalt (eds.). DNA Repair: A Laboratory Manual of Research Procedures, Vol. 1. pp. 379-401. New York: Marcel Dekker. Inc., 1981.
19. Monchi. N., Tapicro. H.,Sugimoto, Y., Bungo. M., Nishiyama, M., Mazouzi, Z., Fourcade, A., Lampidis, T. J., Kasahara. K., Takahashi. T., and Saijo. N. 3′-Deamino-3′-morpholino-13-deoxo-10-hydroxycarminomycin con quers multidrug resistance by rapid influx following higher frequency of formation of DNA single and double strand breaks. Cancer Res., 50: 4698-4701. 1990.
20. Bungo. M., Fujiwara, Y., Kasahara. K., Nakagawa. K., Oha,Y., Sasaki, Y., Irino. S., and Saijo. N. Decreased accumulation as a mechanism of resistance to m-diamminedichloroplatinum(Il) in human non-small cell lung cancer cell lines: Relation to DNA damage and repair. Cancer Res., 50: 2549-2553, 1990.
21. Griffith. O. W. Determination of glutathione and glutathione disulfide using glutathione reducaaseand 2-vinylpyridinc. Anal. Biochem., 706: 207-212, 1980.
22. Habig. W. H., Pabst, M. J., and Jakoby, W. B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249: 7130-7139. 1974.
23. Naganuma, A., Satoh. M., and Humi. N. Prevention of lethal and renal toxicityoffi.Y-diamminedichloroplatinum(II)by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res., 47:983-987, 1987.
24. Kano. T., Sakai. M., and Muramatsu. M. Structure and expression of a human class ir glutathione. V-transferase messenger RNA. Cancer Res., 47: 5626-5630. 1987.
25. Roninson. I. B., Chin, J. E., Choi. K., Gros. P., Housman. D. E., Fojo, A., Shen. D-w., Gottesman. M. M., and Pastan, I. Isolation of human mdr DNA sequences. impililo! in mullidrug-resistant KB carcinoma cells. Proc. Nati. Acad. Sci. USA. 83: 4538-4542. 1986.
26. Krain. M., and Richards. R. I. Human mctallothionein genesaprimary structure of the metallothioncin-II gene and related processed gene. Nature (Lond.). 227: 680-685. 1970.
27. Ahokas. J. T., Davies. C., Ravenscroft. P. J., and Emmcrson. B. T. Inhibition of soluble glutathione 5-transferase by diuretics. Biochem. Pharmacol., 33: 1929-1932, 1984.
28. Kawai. K., Kamatani. N., Georges, E., and Ling. V. Identification of a membrane glycoprotein overexpressed in murine lymphoma sublines resist ant toai-diammincdichloroplatinum(II). J. Biol. Chem., 265:13137-13142. 1990.
29. Hospers, G. A. P., Meuer, C., De Leu, L., Uges, D. R. A., Mulder, N. H., and De Vries. E. G. E. A study of human small-cell lung cancer carcinoma (hSCLC) cell lines with different sensitivities to direct relevant mechanisms of cisplatin (CDDP) resistance. Int. J. Cancer. 46: 138-144. 1990.
30. Basu, A., and Lazo. J. S. A hypothesis regarding the protective role of metallothioneins against the toxicity of DNA interactive anticancer drugs. Toxicol. Lett., 50: 123-135, 1990.
31. Bakka. A., Endresen. L., Johnsen. A. B. S., Ediminson. P. D., and Rugstud. H. E. Resistance against ct.v-diamminedichloroplatinumdl) in cultured cells with a high or low levels of metallothionein. Toxicol. Appi. Pharmacol., 61: 215-226. 1981.
32. Schilder, R. J., Hall. L., Monks, A., Handel, L. M., Fornace. A. J., Jr., Ozols, R. F., Fojo, A. T., and Hamilton, T. C. Metallothionein gene expres sion and resistance to cisplatin in human ovarian cancer. Int. J. Cancer, 45: 416-422, 1990.
33. Schmidt. C. J., and Hammer. D. H. Cell specificity and an effect of ras on human metallothionein gene expression. Proc. Nati. Acad. Sci. USA. 83: 3346-3350. 1986.